China

News

Ascletis says oral acne drug shows "exceptional efficacy"

Phase 3 results for Ascletis' novel acne candidate have set up filings in China and bode well for a similar drug being developed by Sagimet in the US.

News

Report says US biotech needs $15bn support to fend off China

The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.

News

Building site with thre emen in high viz jackets and protective headweare

AZ builds in China, as J&J ramps up its US investments

AstraZeneca will open its sixth R&D centre in China, while J&J announces four new manufacturing facilities in the US in a major reshoring drive.

News

Kelun-Biotech first to bag TROP2 approval in lung cancer

Kelun-Biotech wins first global regulatory approval - in China - for a TROP2-directed antibody-drug conjugate (ADC) in lung cancer.

R&D

Will 2025 be the year the pharmaceutical industry finds its ...

After spending 2024 in recovery mode, the biopharma industry is finally showing signs of growth, climbing back toward its pre-pandemic heights.

R&D

Clinical trends for 2025: A year of change

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and development, particularly in clinical trials.

Ascletis says oral acne drug shows "exceptional efficacy"

Report says US biotech needs $15bn support to fend off China

AZ builds in China, as J&J ramps up its US investments

Kelun-Biotech first to bag TROP2 approval in lung cancer

Will 2025 be the year the pharmaceutical industry finds its ...

Clinical trends for 2025: A year of change

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

China

Editor's Picks